Access cutting-edge macular telangiectasia type 2 treatment through this clinical trial at a research site in La Jolla. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this La Jolla location
Preparing your pre-screening questions…
Access macular telangiectasia type 2 specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular telangiectasia type 2 treatment provided free
Check if you qualify for this macular telangiectasia type 2 clinical trial in La Jolla, CA
No-Cost Study Care
Local to La Jolla
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this global, multicenter, open-label, Phase 4 clinical extension study is to evaluate the long-term safety and efficacy of revakinagene taroretcel-lwey (Encelto™; hereinafter referred to as NT-501), in participants with macular telangiectasia type 2 (MacTel) who previously received the intraocular implant in a Phase 1, Phase 2, or Phase 3 clinical study. In addition, this study will evaluate the safety and efficacy of NT501 in participants who previously underwent the sham procedu
Sponsor: Neurotech Pharmaceuticals
Yes, this clinical trial (NCT06971939) has an active research site in La Jolla, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for macular telangiectasia type 2 treatment options in La Jolla, CA, this clinical trial (NCT06971939) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our La Jolla research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular telangiectasia type 2 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all macular telangiectasia type 2 clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in La Jolla — not just this study.
Browse Pulmonary Embolism Trials in La Jolla →